Orca-T

Phase I Trial for Patients With Advanced Hematologic Malignancies Undergoing Allogeneic Hematopoietic Cell Transplantation From an HLA-Mismatched Donor (7/8) With Orca-T

More Information

Trial Status
Not yet accepting
Trial Phase
Phase 1
Enrollment
24 patients (estimated)
Sponsors
Stanford University Cancer Institute (Palo Alto)
Collaborators
Orca Biosystems, Inc.
Tags
Allogeneic Stem Cell Transplant, T Cell (Allogeneic)
Trial Type
Treatment
Last Update
2 weeks ago
SparkCures ID
1981
NCT Identifier
NCT06551584

Real People. Real Support.

Need help connecting with this clinical trial? We're here to help!

Print this trial to share with your doctor.

We can help answer any questions and connect you (or your patient) with the study team.

Schedule a time that is convenient and we’ll call you to see how we can help you and your patient.